BioHealth News Archive

Breaking the Genome Bottleneck – Technology Review

The genomic data generated from next-generation sequencing machines doesn't amount to much more than alphabet soup if it's not subjected to significant computational processing…

Read More
Supernus moves from IPO to FDA – Washington Business Journal

Supernus moves from IPO to FDA – Washington Business Journal

Supernus Pharmaceuticals Inc. capped off its first week on the Nasdaq up nearly $1 from its initial public offering price. With its IPO in…

Read More
State biotech firms hoping Congress will act – baltimoresun.com

State biotech firms hoping Congress will act – baltimoresun.com

A proposal to speed the approval of new prescription drugs has patient advocates and biotech firms — including many based in Maryland — hoping…

Read More

Should the FDA Approve More Drugs after Phase II? A Response to Matthew Herper – Forbes

Last Friday, Forbes health care editor Matt Herper and I sat down to talk about my proposal, which I detailed in a paper for…

Read More
Biotech Venture Funding Drops 43% in First Quarter | McDonnell Boehnen Hulbert & Berghoff LLP – JDSupra

Biotech Venture Funding Drops 43% in First Quarter | McDonnell Boehnen Hulbert & Berghoff LLP – JDSupra

Last month, the National Venture Capital Association (NVCA), a trade association representing the U.S. venture capital industry, released the results of its MoneyTree Report…

Read More
NIH’s Collins Lauds “Unprecedented” Partnership at NY Bio Confab | Xconomy

NIH’s Collins Lauds “Unprecedented” Partnership at NY Bio Confab | Xconomy

Yesterday at the New York Biotechnology Association’s 21st annual meeting, National Institutes of Health director Francis Collins was beamed in by videoconference to a keynote…

Read More
Cambridge life science sector on record high | Business Weekly | Technology | Biotechnology | Business news | Cambridge and the East of England

Cambridge life science sector on record high | Business Weekly | Technology | Biotechnology | Business news | Cambridge and the East of England

Cambridge’s most prolific life sciences entrepreneur, Andy Richards, says the local cluster is attracting more cash and global kudos than at any time in…

Read More
QIAGEN Acquires AmniSure International to Add Unique Assay to Emerging Point of Need Portfolio – MarketWatch

QIAGEN Acquires AmniSure International to Add Unique Assay to Emerging Point of Need Portfolio – MarketWatch

QIAGEN expands Point of Need portfolio with unique AmniSureassay to detect rupture of fetal membranes (ROM) - checked in up to 30% of U.S.…

Read More
3 Start-Ups Join Loyola Business Accelerator – North Baltimore, MD Patch

3 Start-Ups Join Loyola Business Accelerator – North Baltimore, MD Patch

The first three start-ups have been selected to participate in a new business accelerator program started by Loyola University Maryland. CodePupil, PointClickSwitch.com and Vidstructor…

Read More
Fine-tuning Nanotech to Target Cancer – Technology Review

Fine-tuning Nanotech to Target Cancer – Technology Review

The results of the human trials are startling. Even at a lower-than-usual dose, multiple lung metastases shrank or even disappeared after one patient received…

Read More
Entrepreneurship Ready to “Pop” in Maryland – Citybizlist Baltimore

Entrepreneurship Ready to “Pop” in Maryland – Citybizlist Baltimore

Maryland has the foundation on which it can grow a robust environment of high-tech, innovative start-ups, but needs a stronger angel and venture capital…

Read More
Loyola University Maryland and Wasabi Ventures Name First Business Accelerator Participants – Citybizlist Baltimore

Loyola University Maryland and Wasabi Ventures Name First Business Accelerator Participants – Citybizlist Baltimore

Loyola University Maryland and Wasabi Ventures, a California-based venture capital firm with a presence in Baltimore, named the first three companies participating in the…

Read More
New Enterprise Associates Grabs Four Spots on Forbes Midas List of Top Tech Investors – cbl – Citybizlist Washington DC

New Enterprise Associates Grabs Four Spots on Forbes Midas List of Top Tech Investors – cbl – Citybizlist Washington DC

Four New Enterprise Associates (NEA) venture capitalists were named to Forbes Midas List of Tech Investors, which aims to single out the top 100…

Read More
Bioeconomy Blueprint Embraces Public-Private Efforts, Avoids Grand Challenges

Bioeconomy Blueprint Embraces Public-Private Efforts, Avoids Grand Challenges

President Barack Obama’s administration rolled out its National Bioeconomy Blueprint last week, on April 26. It details measures by which Washington intends to apply…

Read More
Pfizer Profit Declines 19% After Loss of Lipitor Patent – NYTimes.com

Pfizer Profit Declines 19% After Loss of Lipitor Patent – NYTimes.com

For years, drug companies have known that their days of plenty were numbered, that the moment would arrive when the best-selling drugs that had…

Read More